| News

Switzerland Innovation Park Basel Area opens site in Jura

22.10.2019

Switzerland Innovation Park Basel Area has opened its third location. The park is now represented in Jura alongside its locations in the Cantons of Basel-Landschaft and Basel-Stadt. This represents something of a milestone for the operators BaselArea.swiss.

Opening with Georges Humard (president CCIJ), Hans-Florian Zeilhofer (University of Basel), Domenico Scala (president BaselArea.swiss), Jacques Gerber (president of the government Canton Jura), Elisabeth Ackermann (president of the government Canton Basel-Stadt), Gabriel Voirol (president of the parliament Canton Jura) (1st row, from left to right)

Switzerland Innovation Park Basel Area is now represented in all three supporting cantons of the operators BaselArea.swiss. Following on from locations in Basel and Allschwil BL, a third location was opened in Courroux. Domenico Scala, President of BaselArea.swiss, described this milestone: “We have now successfully closed the circle”.

The new location will focus on the field of medical technology, health technology, digital health and industrial transformation. A usable area of 1,200 square meters will be available for these pursuits. SMEs and start-ups will be able to use the office space to further develop their visions and secure success. In addition, BaselArea.swiss is offering relevant support programs to this end in the form of DayOne and i4Challenge. The first companies are already moving in to the Switzerland Innovation Park Basel Area, for example the software development company NextDay.Vision, which is based in Jura. In November, the start-up Ersys, which is active in the field of system ergonomics, will follow NextDay.Vision’s suit. The Research and Development Center for Micro and Nanotechnology CSEM will be offering consultancy from November onwards at the new location. At the same time, a total of 1.6 million Swiss francs is being invested in the expansion of the two floors of the building, which will be of benefit to the Jura economy.

The Canton of Jura has also been supporting the creation of this new location right from the very beginning of the projects. Jacques Gerber, President of the Jura Cantonal Government and Minister of Economic Affairs and Healthcare, has indicated that the Jura economy can flourish on the back of the Switzerland Innovation Park Basel Area by tapping into the innovation ecosystem. Moreover, Claude-Henri Schaller, Head of the Cantonal Office for Economics and Labor, commented: “We have poured all our energy into offering the best-possible framework conditions for the Jura economy. I think that we have managed to meet these requirements”.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.